AzTrials
AzTrials

AnkyloglossiaNCT01550354

Comparison Among Propofol, Alfentanil and Rocuronium as Adjunct to Sevoflurane Anesthesia for Endotracheal Intubation in Children With Frenectomy

A study testing administration of propofol, administration of alfentanil and administration of rocuronium in people with Ankyloglossia, run by Yonsei University at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several methods have been demonstrated to improve intubating conditions during sevoflurane induction in children. These include opioids, propofol, and addition of neuromuscular blocking agents in pediatric patients. But the study about the comparison of these agents has been uncommon. Read more about this study

Who is it for?
Ages 1 year to 9 years
Conditions the study is for
Ankyloglossia
What is being tested?
administration of propofol, administration of alfentanil and administration of rocuronium
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
114 participants
Where
1 siteSouth Korea
Study dates
Feb 2012to Jan 2014
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 year to 9 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Children, 1-9 years old scheduled elective frenectomy under general anesthesia

Who cannot join

  • Patients with an abnormal airway, reactive airway disease, gastroesophageal reflux disease, chronic respiratory disease, or a history of an upper respiratory tract infection in the preceding 6-week period

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Severance hospital

    Seoul

Other trials in South Korea

About this study

Several methods have been demonstrated to improve intubating conditions during sevoflurane induction in children. These include opioids, propofol, and addition of neuromuscular blocking agents in pediatric patients. But the study about the comparison of these agents has been uncommon. Frenectomy is common procedure to treat ankyloglossia. It is a short procedure performed under general anesthesia. The investigators aimed to compare intubating conditions among children with propofol, alfentanil or rocuronium after sevoflurane induction.

Conditions
Ankyloglossia
Being tested
administration of propofol, administration of alfentanil, administration of rocuronium
Medical subject headings
Ankyloglossia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • administration of propofolDrug

    intravenous administration of propofol 2 mg/kg before intubation

  • administration of alfentanilDrug

    intravenous administration of alfentanil 14 μg/kg before intubation

  • administration of rocuroniumDrug

    Intravenous administration of rocuronium 0.3 mg/kg before intubation

Study groups in NCT01550354
Study groupRoleWhat they receive
Propofol groupActive comparatorIntravenous administration of propofol 2 mg/kg before intubation
Receives: Drug: administration of propofol
Alfentanil groupActive comparatorIntravenous administration of alfentanil 14 μg/kg before intubation
Receives: Drug: administration of alfentanil
Rocuronium groupActive comparatorIntravenous administration of rocuronium 0.3 mg/kg before intubation
Receives: Drug: administration of rocuronium

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Intubating condition

    The investigators will perform the evaluation of intubating condtion through scoring system provided by Viby-Mogensen during intubation procedure. The scoring system is consisted of excellent, good, and poor.

    Measured: Participants will be followed for the duration of intubation, an expected average of 1 minute.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Mar 2012 (estimated)
  2. Study startFeb 2012
  3. Primary completionJan 2014
  4. Study completionJan 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Care provider, Investigator
Enrolment
114 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01550354
Sponsor's protocol ID
4-2011-0824
Status last verified
Jun 2021
First submitted
22 Feb 2012
Last updated
7 Jun 2021
Results posted
No
Data monitoring committee
Yes

Publications

  • Park S, Kim JH, Bae JC, Lee JR, Kim MS. Tracheal intubation with or without a neuromuscular blocking agent for a short surgical procedure in children: Prospective, randomized, double-blind trial. Paediatr Anaesth. 2021 Aug;31(8):863-870. doi: 10.1111/pan.14205. Epub 2021 Jun 3.

    PubMed 33993571

Questions about this trial

What is this clinical trial studying?

A study testing administration of propofol, administration of alfentanil and administration of rocuronium in people with Ankyloglossia, run by Yonsei University at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Intubating condition (time frame: Participants will be followed for the duration of intubation, an expected average of 1 minute.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01550354, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jun 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in